Eisele Jeffrey 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Eisele Jeffrey
Chief Development Officer
Transactions
- Sale
Common Stock
2025-01-13$28.70/sh−264$7,577→ 56,881 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.